Community Oncology Alliance
Video Player is loading.
10 seconds
Playback speed
2021 Update on EGFR Exon20ins in mNSCLC: Bispecific Antibody vs. TKI Therapy Outcomes in Previously Treated Disease
By
2021 Community Oncology Conference
FEATURING
Alex Spira
By
2021 Community Oncology Conference
FEATURING
Alex Spira
This video was completed prior to amivantamab receiving FDA approval on 05/21/2021 and mobocertinib receiving ...
read more ↘
read more ↘
Comments 0
Login to view comments.
Click here to Login
